Compounds > thioflavin t
Page last updated: 2024-08-22

thioflavin t and Neoplasms

thioflavin t has been researched along with Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, Y; Li, H; Luo, X; Nie, Z; Shi, T; Wang, HH; Wang, M; Yao, S1
Ashraf, MI; Cutress, RI; Deutsch, M; Enthammer, M; Khalid, S; Koziel, K; Packham, G; Papadakis, ES; Salomé Gachet, M; Schwaiger, S; Stuppner, H; Troppmair, J; Wolber, G1
Ano Bom, AP; Braga, CA; Cepeda, AO; Cordeiro, Y; Costa, DC; De Moura Gallo, CV; de Oliveira, GA; Gava, LM; Ramos, CH; Rangel, LP; Sanches, D; Silva, JL; Stumbo, AC1
Boeckler, FM; Fersht, AR; Wang, G; Wilcken, R1
DiGiammarino, EL; Galea, C; Jun, B; Kriwacki, RW; Lee, AS; Murti, G; Ribeiro, RC; Schultz, CP; Zambetti, G1
Zółtowska, A1

Other Studies

6 other study(ies) available for thioflavin t and Neoplasms

ArticleYear
Simultaneous Monitoring of Cell-surface Receptor and Tumor-targeted Photodynamic Therapy via TdT-initiated Poly-G-Quadruplexes.
    Scientific reports, 2018, 04-03, Volume: 8, Issue:1

    Topics: A549 Cells; Aptamers, Nucleotide; Benzothiazoles; Cell Survival; Drug Delivery Systems; Fluorescent Dyes; G-Quadruplexes; Hep G2 Cells; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Receptors, Cell Surface

2018
Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:11

    Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzothiazoles; Binding Sites; Butadienes; Cell Line; Cell Proliferation; DNA-Binding Proteins; Fluorescent Dyes; HEK293 Cells; HSC70 Heat-Shock Proteins; Humans; Indoles; MCF-7 Cells; Mice; Molecular Docking Simulation; Neoplasms; NIH 3T3 Cells; Nitriles; Protein Binding; Proto-Oncogene Proteins B-raf; Sulfonamides; Thiazoles; Transcription Factors; Vemurafenib

2013
Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.
    The Journal of biological chemistry, 2012, Aug-10, Volume: 287, Issue:33

    Topics: Amino Acid Substitution; Amyloid; Benzothiazoles; Humans; Mutation, Missense; Neoplasms; Prions; Protein Multimerization; Protein Structure, Quaternary; Protein Structure, Secondary; Thiazoles; Tumor Suppressor Protein p53; X-Ray Diffraction

2012
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Aug-21, Volume: 109, Issue:34

    Topics: Amyloid; Benzothiazoles; Humans; Kinetics; Ligands; Light; Microscopy, Electron; Mutation; Neoplasms; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Scattering, Radiation; Thiazoles; Tumor Suppressor Protein p53

2012
Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
    Journal of molecular biology, 2003, Mar-28, Volume: 327, Issue:3

    Topics: Amyloid; Benzothiazoles; Circular Dichroism; Coloring Agents; Congo Red; Dose-Response Relationship, Drug; Guanidine; Hot Temperature; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Microscopy, Electron; Mutation; Neoplasms; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Temperature; Thiazoles; Time Factors; Tumor Suppressor Protein p53

2003
Cancer and thymus extract.
    Archivum immunologiae et therapiae experimentalis, 1987, Volume: 35, Issue:5

    Topics: Adolescent; Adult; Animals; Antibodies; Antigen-Antibody Reactions; Carcinoma; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Neoplasms; Rabbits; Thymus Extracts

1987